The expression of inflammatory cytokines on the aorta endothelia are up-regulated in pinealectomized rats

Inflammation

Volumn 36, Issue 6, 2013, Pages 1363-1373

  Wang, Yu ^a   Liu, Xiaoyan ^b   Wang, Wei ^a   Song, Wei ^a   Chen, Lianfeng ^a   Fang, Quan ^a   Yan, Xiaowei ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^b BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

endothelial inflammation; inflammatory cytokines; melatonin; signal pathways

Indexed keywords

C REACTIVE PROTEIN; CYTOKINE; FATTY ACID; GELATINASE B; GLUCOSE; INTERLEUKIN 6; MALONALDEHYDE; MELATONIN; MITOGEN ACTIVATED PROTEIN KINASE P38; MONOCYTE CHEMOTACTIC PROTEIN 1; OXIDIZED LOW DENSITY LIPOPROTEIN; TRANSCRIPTION FACTOR RELA; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ANIMAL CELL; ANIMAL TISSUE; AORTA; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ENDOTHELIUM; ENDOTHELIUM CELL; FATTY ACID BLOOD LEVEL; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HORMONE DEFICIENCY; IN VITRO STUDY; MALE; NONHUMAN; OXIDATIVE STRESS; PINEALECTOMY; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; TRIACYLGLYCEROL BLOOD LEVEL; UPREGULATION;

RATTUS;

ANIMALS; AORTA; C-REACTIVE PROTEIN; CELL LINE; CHEMOKINE CCL2; ENDOTHELIUM, VASCULAR; GLUCOSE; INFLAMMATION; INTERLEUKIN-6; LIPIDS; MALE; MALONDIALDEHYDE; MATRIX METALLOPROTEINASE 9; MELATONIN; OXIDATIVE STRESS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PINEAL GLAND; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION; VASCULAR CELL ADHESION MOLECULE-1;

EID: 84888200248     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-013-9676-1     Document Type: Article

References (46)

1. Usui, T., M. Okada, Y. Hara, et al. 2012. Death-associated protein kinase 3 mediates vascular inflammation and development of hypertension in spontaneously hypertensive rats. Hypertension 60: 1031-1039.
2. Seijkens, T., P. Kusters, D. Engel, et al. 2013. CD40-CD40L: Linking pancreatic, adipose tissue and vascular inflammation in type 2 diabetes and its complications. Diabetes & Vascular Disease Research 10: 115-122.
3. Arzamastsev, D.D., A.A. Karpenko, and G.I. Kostiuchenko. 2012. Inflammation of the vascular wall and hyperhomocysteinemia in patients with atherosclerosis obliterans of lower limb arteries. Angiol Sosud Khir 18: 27-30.
4. Tsimikas, S., and Y.I. Miller. 2011. Oxidative modification of lipoproteins: Mechanisms, role in inflammation and potential clinical applications in cardiovascular disease. Current Pharmaceutical Design 17: 27-37.
5. Chen, B., D. Guan, Z.J. Cui, et al. 2010. Thioredoxin 1 downregulates MCP-1 secretion and expression in human endothelial cells by suppressing nuclear translocation of activator protein 1 and redox factor-1. American Journal of Physiology. Cell Physiology 298: C1170-C1179.
6. Jia, Y., P. Gao, H. Chen, et al. 2013. SIRT1 suppresses PMA and ionomycin-induced ICAM-1 expression in endothelial cells. Science China. Life Sciences 56: 19-25.
7. Zhang, F., J. Ren, K. Chan, et al. 2013. Angiotensin-(1-7) regulates Angiotensin II-induced VCAM-1 expression on vascular endothelial cells. Biochemical and Biophysical Research Communications 430: 642-646.
8. Cossette, E., I. Cloutier, K. Tardif, et al. 2013. Estradiol inhibits vascular endothelial cells pro-inflammatory activation induced by C-reactive protein. Molecular and Cellular Biochemistry 373: 137-147.
9. Karasek, M., and K. Winczyk. 2006. Melatonin in humans. Journal of Physiology and Pharmacology 57(Suppl 5): 19-39.
10. Drugs for sleep disorders: Mechanisms and therapeutic prospects. British Journal of Clinical Pharmacology 2006; 61:761-766.
11. Szczepanik, M. 2007. Melatonin and its influence on immune system. Journal of Physiology and Pharmacology 58(Suppl 6): 115-124.
12. Shirazi, A., G. Ghobadi, and M. Ghazi-Khansari. 2007. A radiobiological review on melatonin: A novel radioprotector. J Radiat Res (Tokyo) 48: 263-272.
13. Mj, R.-L. 2010. Cano P, Jimenez-Ortega V et al. Melatonin effect on plasma adiponectin, leptin, insulin, glucose, triglycerides and cholesterol in normal and high fat-fed rats. Journal of Pineal Research 49: 342-348.
14. Grinenko, T.N., M.F. Balliuzek, and T.V. Kvetnaia. 2012. Melatonin as a marker of intensity of structural and functional changes in the heart and vessels of the patients presenting with metabolic syndrome. Klin Med (Mosk) 90: 30-34.
15. Agil, A., R.J. Reiter, A. Jimenez-Aranda, et al. 2012. Melatonin ameliorates low-grade inflammation and oxidative stress in young Zucker diabetic fatty rats. Journal of Pineal Research 54: 381-388.
16. Maganhin, C.C., R.S. Simoes, L.F. Fuchs, et al. 2009. Rat pinealectomy: A modified direct visual approach. Acta Cirúrgica Brasileira 24: 321-324.
17. Lepara, O., A. Valjevac, A. Alajbegovic, et al. 2009. Decreased serum lipids in patients with probable Alzheimer's disease. Bosnian Journal of Basic Medical Sciences 9: 215-220.
18. Mania, M., L. Javashvili, S. Kasradze, et al. 2011. Fasting insulin and HOMA-index changes in patients treated with valproic acid. Georgian Medical News 199: 48-52.
19. Zhang, C., H. Zheng, Q. Yu, et al. 2010. A practical method for quantifying atherosclerotic lesions in rabbits. Journal of Comparative Pathology 142: 122-128.
20. Nishida, S., R. Sato, I. Murai, et al. 2003. Effect of pinealectomy on plasma levels of insulin and leptin and on hepatic lipids in type 2 diabetic rats. Journal of Pineal Research 35: 251-256.
21. Yamamura, T., and M. Ishigami. 2010. Cutting-edge research on the metabolism of remnant lipoproteins. Rinsho Byori 58: 613-621.
22. Pu, D.R., and L. Liu. 2007. Remnant like particles may induce atherosclerosis via accelerating endothelial progenitor cells senescence. Medical Hypotheses 69: 293-296.
23. Bush, N.C., R. Basu, R.A. Rizza, et al. 2012. Insulin-mediated FFA suppression is associated with triglyceridemia and insulin sensitivity independent of adiposity. Journal of Clinical Endocrinology and Metabolism 97: 4130-4138.
24. Peschke, E. 2008. Melatonin, endocrine pancreas and diabetes. Journal of Pineal Research 44: 26-40.
25. Korkmaz, A., R.J. Reiter, T. Topal, et al. 2009. Melatonin: An established antioxidant worthy of use in clinical trials. Molecular Medicine 15: 43-50.
26. Kaneko, S., K. Okumura, Y. Numaguchi, et al. 2000. Melatonin scavenges hydroxyl radical and protects isolated rat hearts from ischemic reperfusion injury. Life Sciences 67: 101-112.
27. Dominguez-Rodriguez, A., P. Abreu-Gonzalez, and P. Avanzas. 2012. The role of melatonin in acute myocardial infarction. Frontiers in Bioscience 17: 2433-2441.
28. Mogulkoc, R., A.K. Baltaci, L. Aydin, et al. 2005. Pinealectomy inhibits antioxidant system in rats with hyperthyroidism. Neuro Endocrinology Letters 26: 795-798.
29. Chen, S.J., C.H. Yen, Y.C. Huang, et al. 2012. Relationships between inflammation, adiponectin, and oxidative stress in metabolic syndrome. PLoS One 7: e45693.
30. Itabe, H. 2009. Oxidative modification of LDL: Its pathological role in atherosclerosis. Clinical Reviews in Allergy & Immunology 37: 4-11.
31. Bruunsgaard, H., P. Skinhoj, A.N. Pedersen, et al. 2000. Ageing, tumour necrosis factor-alpha (TNF-alpha) and atherosclerosis. Clinical and Experimental Immunology 121: 255-260.
32. Nishida, M., T. Moriyama, K. Ishii, et al. 2007. Effects of IL-6, adiponectin, CRP and metabolic syndrome on subclinical atherosclerosis. Clinica Chimica Acta 384: 99-104.
33. Sekalska, B. 2003. Aortic expression of monocyte chemotactic protein-1 (MCP-1) gene in rabbits with experimental atherosclerosis. Annales Academiae Medicae Stetinensis 49: 79-90.
34. Ling, S., L. Nheu, and P.A. Komesaroff. 2012. Cell adhesion molecules as pharmaceutical target in atherosclerosis. Mini Reviews in Medicinal Chemistry 12: 175-183.
35. Valastyan, S., and R.A. Weinberg. 2011. Roles for microRNAs in the regulation of cell adhesion molecules. Journal of Cell Science 124: 999-1006.
36. Arnett, D.K., R.L. Mcclelland, A. Bank, et al. 2011. Biomarkers of inflammation and hemostasis associated with left ventricular mass: The Multiethnic Study of Atherosclerosis (MESA). Int J Mol Epidemiol Genet 2: 391-400.
37. Thompson, W.L., and L.J. Van Eldik. 2009. Inflammatory cytokines stimulate the chemokines CCL2/MCP-1 and CCL7/MCP-3 through NFκB and MAPK dependent pathways in rat astrocytes [corrected]. Brain Research 1287: 47-57.
38. Loizou, S., S. Paraschos, S. Mitakou, et al. 2009. Chios mastic gum extract and isolated phytosterol tirucallol exhibit anti-inflammatory activity in human aortic endothelial cells. Experimental Biology and Medicine (Maywood, N.J.) 234: 553-561.
39. Li, W., H. Li, A.D. Bocking, et al. 2010. Tumor necrosis factor stimulates matrix metalloproteinase 9 secretion from cultured human chorionic trophoblast cells through TNF receptor 1 signaling to IKBKB-NFKB and MAPK1/3 pathway. Biology of Reproduction 83: 481-487.
40. Tang, Z., L. Jiang, J. Peng, et al. 2012. PCSK9 siRNA suppresses the inflammatory response induced by oxLDL through inhibition of NF-kappaB activation in THP-1-derived macrophages. International Journal of Molecular Medicine 30: 931-938.
41. Qin, W., W. Lu, H. Li, et al. 2012. Melatonin inhibits IL1beta-induced MMP9 expression and activity in human umbilical vein endothelial cells by suppressing NF-kappaB activation. Journal of Endocrinology 214: 145-153.
42. Chen, Xl, Dodd G, Kunsch C. 2009. Sulforaphane inhibits TNF-alpha-induced activation of p38 MAP kinase and VCAM-1 and MCP-1 expression in endothelial cells. Inflammation Research 58: 513-521.
43. Aomatsu, T., H. Imaeda, K. Takahashi, et al. 2012. Tacrolimus (FK506) suppresses TNF-alpha-induced CCL2 (MCP-1) and CXCL10 (IP-10) expression via the inhibition of p38 MAP kinase activation in human colonic myofibroblasts. International Journal of Molecular Medicine 30: 1152-1158.
44. Choi, H.J., T.W. Chung, J.E. Kim, et al. 2012. Aesculin inhibits matrix metalloproteinase-9 expression via p38 mitogen activated protein kinase and activator protein 1 in lipopolysaccharide-induced RAW264.7 cells. International Immunopharmacology 14: 267-274.
45. Dong, Y.J., C.H. Ding, W.W. GU, et al. 2010. Inhibitory effects of melatonin on the expression of phosphorylation p38 mitogen-activated protein kinase during acute lung injury in rats. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 22: 418-421.
46. Esposito, E., T. Genovese, R. Caminiti, et al. 2009. Melatonin reduces stress-activated/mitogen-activated protein kinases in spinal cord injury. Journal of Pineal Research 46: 79-86.